Fair Value Measurements - Narrative (Details) - USD ($) |
3 Months Ended | 6 Months Ended | |||
|---|---|---|---|---|---|
Jul. 31, 2026 |
Jul. 31, 2025 |
Jul. 31, 2026 |
Jul. 31, 2025 |
Feb. 07, 2025 |
|
| Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||||
| Equity securities without readily determinable fair value, upward price adjustment, annual amount | $ 0.0 | $ 500,000 | |||
| Cumulative unrealized gains | $ 700,000 | 700,000 | |||
| Impairment loss | $ 0 | $ 0 | 0 | 0 | |
| Realized investment gains | $ 0.0 | $ 1,200,000 | |||
| Sandbox | |||||
| Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||||
| Potential payment | $ 10,000,000.0 | ||||
| X | ||||||||||
- Definition Maximum amount of estimate for undiscounted range of outcomes in contingent consideration arrangement in business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of impairment loss on investment in equity security without readily determinable fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of gain from upward price adjustment on investment in equity security without readily determinable fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|